Quinolinone derivatives as tyrosine kinase inhibitors
摘要
Organic compounds having the formulas I and II are provided where the variables have the values described herein. Pharmaceutical formulations include the organic compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and may be prepared by mixing the organic compounds with a carrier and water. A method of treating a patient includes administering a pharmaceutical formulation according to the invention to a patient in need thereof.
申请公布号
EP1849782(A1)
申请公布日期
2007.10.31
申请号
EP20070011978
申请日期
2001.09.11
申请人
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
发明人
RENHOWE, PAUL;PECCHI, SABINA;MACHAJEWSKI, TIM;SHAFER, CYNTHIA;TAYLOR, CLARKE;MCCREA, BILL;MCBRIDE, CHRIS;JAZAN, ELISA;WERNETTE-HAMMOND, MARY-ELLEN;HARRIS, ALEX L.